Cargando…
Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study
OBJECTIVES: This study aimed to explore the effectiveness of mindfulness-based relapse prevention (MBRP) with individuals receiving medication for opioid use disorder (MOUD) in a naturalistic, open-ended outpatient group treatment setting. METHODS: Eighty participants (mean age 36.3) who had at leas...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504564/ https://www.ncbi.nlm.nih.gov/pubmed/34659584 http://dx.doi.org/10.1007/s12671-021-01763-w |
_version_ | 1784581343870451712 |
---|---|
author | Zullig, Keith J. Lander, Laura R. Tuscano, Meghan Garland, Megan Hobbs, Gerry R. Faulkenberry, Laurel |
author_facet | Zullig, Keith J. Lander, Laura R. Tuscano, Meghan Garland, Megan Hobbs, Gerry R. Faulkenberry, Laurel |
author_sort | Zullig, Keith J. |
collection | PubMed |
description | OBJECTIVES: This study aimed to explore the effectiveness of mindfulness-based relapse prevention (MBRP) with individuals receiving medication for opioid use disorder (MOUD) in a naturalistic, open-ended outpatient group treatment setting. METHODS: Eighty participants (mean age 36.3) who had at least 90 consecutive days substance free self-selected into treatment (MBRP, n = 35) or comparison groups (treatment as usual, TAU, n = 45). Outcomes tracked included treatment retention and relapse, and self-reported craving, anxiety, depression, and mindfulness at baseline, 12 weeks, 24 weeks, and 36 weeks post-recruitment. MBRP group participants attended biweekly 60-min sessions for 24 weeks. A linear mixed model analysis of variance determined the significance of the MBRP intervention on changes in craving, anxiety, depression, and mindfulness. RESULTS: No significant differences in sex, education level, insurance status, relationship status, or employment status were detected at baseline between groups. The 36-week retention (74%, MBRP/MOUD; 71%, TAU/MOUD) and relapse rates (43%, MBRP/MOUD; 47%, TAU/MOUD) were similar for the groups. There were only four relapses on opioids. Significant reductions (p < .05) were observed in the MBRP/MOUD group for craving, anxiety, and depression in addition to significant increases in mindfulness compared to those in TAU/MOUD. CONCLUSIONS: Although state and federal resources are available to expand MOUD, no standard of behavioral therapy has been established as most complimentary to MOUD. The current study results suggest MBRP can be implemented as an outpatient therapy for individuals in MOUD. |
format | Online Article Text |
id | pubmed-8504564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85045642021-10-12 Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study Zullig, Keith J. Lander, Laura R. Tuscano, Meghan Garland, Megan Hobbs, Gerry R. Faulkenberry, Laurel Mindfulness (N Y) Original Paper OBJECTIVES: This study aimed to explore the effectiveness of mindfulness-based relapse prevention (MBRP) with individuals receiving medication for opioid use disorder (MOUD) in a naturalistic, open-ended outpatient group treatment setting. METHODS: Eighty participants (mean age 36.3) who had at least 90 consecutive days substance free self-selected into treatment (MBRP, n = 35) or comparison groups (treatment as usual, TAU, n = 45). Outcomes tracked included treatment retention and relapse, and self-reported craving, anxiety, depression, and mindfulness at baseline, 12 weeks, 24 weeks, and 36 weeks post-recruitment. MBRP group participants attended biweekly 60-min sessions for 24 weeks. A linear mixed model analysis of variance determined the significance of the MBRP intervention on changes in craving, anxiety, depression, and mindfulness. RESULTS: No significant differences in sex, education level, insurance status, relationship status, or employment status were detected at baseline between groups. The 36-week retention (74%, MBRP/MOUD; 71%, TAU/MOUD) and relapse rates (43%, MBRP/MOUD; 47%, TAU/MOUD) were similar for the groups. There were only four relapses on opioids. Significant reductions (p < .05) were observed in the MBRP/MOUD group for craving, anxiety, and depression in addition to significant increases in mindfulness compared to those in TAU/MOUD. CONCLUSIONS: Although state and federal resources are available to expand MOUD, no standard of behavioral therapy has been established as most complimentary to MOUD. The current study results suggest MBRP can be implemented as an outpatient therapy for individuals in MOUD. Springer US 2021-10-11 2021 /pmc/articles/PMC8504564/ /pubmed/34659584 http://dx.doi.org/10.1007/s12671-021-01763-w Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Zullig, Keith J. Lander, Laura R. Tuscano, Meghan Garland, Megan Hobbs, Gerry R. Faulkenberry, Laurel Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study |
title | Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study |
title_full | Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study |
title_fullStr | Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study |
title_full_unstemmed | Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study |
title_short | Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study |
title_sort | testing mindfulness-based relapse prevention with medications for opioid use disorder among adults in outpatient therapy: a quasi-experimental study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504564/ https://www.ncbi.nlm.nih.gov/pubmed/34659584 http://dx.doi.org/10.1007/s12671-021-01763-w |
work_keys_str_mv | AT zulligkeithj testingmindfulnessbasedrelapsepreventionwithmedicationsforopioidusedisorderamongadultsinoutpatienttherapyaquasiexperimentalstudy AT landerlaurar testingmindfulnessbasedrelapsepreventionwithmedicationsforopioidusedisorderamongadultsinoutpatienttherapyaquasiexperimentalstudy AT tuscanomeghan testingmindfulnessbasedrelapsepreventionwithmedicationsforopioidusedisorderamongadultsinoutpatienttherapyaquasiexperimentalstudy AT garlandmegan testingmindfulnessbasedrelapsepreventionwithmedicationsforopioidusedisorderamongadultsinoutpatienttherapyaquasiexperimentalstudy AT hobbsgerryr testingmindfulnessbasedrelapsepreventionwithmedicationsforopioidusedisorderamongadultsinoutpatienttherapyaquasiexperimentalstudy AT faulkenberrylaurel testingmindfulnessbasedrelapsepreventionwithmedicationsforopioidusedisorderamongadultsinoutpatienttherapyaquasiexperimentalstudy |